Department of Neurology, Northwestern University, Chicago, Illinois.
JAMA Neurol. 2013 Sep 1;70(9):1126-32. doi: 10.1001/jamaneurol.2013.293.
Implementation of prehospital stroke triage is a public policy intervention that can have an immediate impact on acute stroke care in a region. OBJECTIVE To evaluate the impact that a citywide policy recommending prehospital triage of patients with suspected stroke to the nearest primary stroke center had on intravenous tissue plasminogen activator (tPA) use in Chicago, Illinois.
Retrospective multicenter cohort study from September 1, 2010, to August 31, 2011 (6 months before and after intervention that began March 1, 2011).
Ten primary stroke center hospitals in Chicago.
All admitted patients with stroke and transient ischemic attack. INTERVENTION Prehospital triage policy of patients with stroke to primary stroke centers.
Intravenous tPA use (measured as a fraction of patients with ischemic strokes arriving through the emergency department). RESULTS There were 1075 stroke and transient ischemic attack admissions in the pretriage period and 1172 in the posttriage period. Patient demographic characteristics including age, sex, and risk factors were similar between the 2 periods (mean age, 65 years; 53% female). Compared with the pretriage period, use of emergency medical services increased from 30.2% to 38.1% (P < .001) and emergency medical services prenotification increased from 65.5% to 76.5% (P = .001) after implementation. Rates of intravenous tPA use were 3.8% and 10.1% (P < .001) and onset-to-treatment times decreased from 171.7 to 145.7 minutes (P = .03) in the pretriage and posttriage periods, respectively. Stroke unit admission, symptomatic intracranial hemorrhage rates, and in-hospital mortality were not significantly different between periods. Adjusting for mode of arrival, prehospital notification, and onset-to-arrival time, the posttriage period was independently associated with increased tPA use for patients with ischemic stroke presenting through the emergency department (adjusted odds ratio = 2.21; 95% CI, 1.34-3.64).
Implementation of a prehospital stroke triage policy in Chicago resulted in significant improvements in emergency medical services use and prenotification and more than doubled intravenous tPA use at primary stroke centers.
实施院前卒中分诊是一项公共政策干预措施,可对该地区的急性卒中护理产生直接影响。目的:评估一项推荐将疑似卒中患者分诊至最近的初级卒中中心的全市政策对伊利诺伊州芝加哥市静脉注射组织型纤溶酶原激活剂(tPA)使用的影响。
2010 年 9 月 1 日至 2011 年 8 月 31 日(干预前 6 个月,干预于 2011 年 3 月 1 日开始)的回顾性多中心队列研究。
芝加哥的 10 家初级卒中中心医院。
所有卒中及短暂性脑缺血发作入院患者。干预:对卒中患者进行初级卒中中心的院前分诊政策。
静脉 tPA 使用情况(以通过急诊到达的缺血性卒中患者的分数表示)。结果:在分诊前时期有 1075 例卒中及短暂性脑缺血发作入院,在分诊后时期有 1172 例。两个时期患者的人口统计学特征(包括年龄、性别和危险因素)相似(平均年龄 65 岁;53%为女性)。与分诊前时期相比,使用急诊医疗服务的比例从 30.2%增加到 38.1%(P<.001),急诊医疗服务预先通知的比例从 65.5%增加到 76.5%(P=.001)。静脉 tPA 的使用率分别为 3.8%和 10.1%(P<.001),分诊前和分诊后时期的发病至治疗时间分别从 171.7 分钟减少到 145.7 分钟(P=.03)。卒中单元入院率、症状性颅内出血率和住院死亡率在两个时期无显著差异。调整到达模式、院前通知和发病至到达时间后,分诊后时期与通过急诊就诊的缺血性卒中患者 tPA 使用率的增加独立相关(调整后优势比=2.21;95%CI,1.34-3.64)。
在芝加哥实施院前卒中分诊政策后,急诊医疗服务的使用和预先通知显著改善,初级卒中中心的静脉注射 tPA 使用量增加了一倍以上。